Product Information

BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET is a generic product labeled by AvPAK, priced at $0.1204 per EA under NDC 50268055313. Its NADAC has been published 193 times since Mar 15, 2023.

FDA first approved this application on Oct 31, 2018. Its Orange Book therapeutic-equivalence code is AA.

BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET

Butalbital, Acetaminophen, and Caffeine
$0.1204per EA
DEA Schedule CIII

Strength

325; 50; 40 mg/1; mg/1; mg/1

Manufacturer

AvPAK

NDC

50268055313

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA209587

FDA Approved

10/31/2018

TE Code

AA

On Market Since

8/11/2022

Pharmacological Classes

Barbiturate
Barbiturates
Central Nervous System Stimulant
Central Nervous System Stimulation
Methylxanthine
Xanthines

Price Statistics

The NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET has been published 193 times since Mar 15, 2023, and over the history we have for it it has declined 18.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1204 per EA
All-time high$0.1664 (Oct 16, 2024)
All-time low$0.1112 (Nov 20, 2024)
52-week high$0.1398
52-week low$0.1204
Median price$0.1439
Average price$0.1419
Largest weekly change+35.2% (Aug 21, 2024)
Weeks tracked193
Tracking sinceMar 15, 2023

Price History

1W

-0.3%

1M

-1.6%

3M

-2.4%

6M

-1.9%

1Y

-12.7%

3Y

-20.7%

5Y

N/A

All

-18.5%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET, manufactured by AvPAK, is $0.1204 per EA (NDC 50268055313), effective Nov 18, 2026.

How has the price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET changed over time?

Over the history we have for it, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET has declined 18.5%. It has been tracked across 193 weekly CMS publications since Mar 15, 2023.

What are the highest and lowest recorded NADAC prices for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET?

Since Mar 15, 2023, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET has ranged from a low of $0.1112 (Nov 20, 2024) to a high of $0.1664 (Oct 16, 2024), with a median of $0.1439 per EA.

Are there cheaper alternatives to BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET?

BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-325-40 MG TABLET (NDC 50268055313) is labeled by AvPAK, and CMS classifies it as a generic product.